Endocrine oncology

Evaluating Disease-specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer

J Clin Endocrinol MetabPublished Retrospective cohort study

Authors' conclusion

In a European population of patients with DTC, of 10 international guidelines using 6 risk of recurrence stratification systems and 1 mortality-based stratification system, our optimized age-adjusted TNM system (8th edition) outperformed all other systems.

Study context

Population
Adults with differentiated thyroid cancer (DTC) (79% PTC, 21% FTC) from a Dutch university hospital
Participants
857 adults
Exposure
Risk stratification systems of 10 international guidelines vs TNM system (8th edition) for predicting disease-specific survival (DSS)
Outcome
Disease-specific survival (DSS) prediction: C-index, Akaike and Bayesian information criteria, proportion of variance explained
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Statistical model performance for predicting DSS
  • Dutch guideline had the worst statistical model performance
  • 2009 American Thyroid Association (ATA)/2014 British guideline had the best performance among guidelines
  • The (adapted) TNM system outperformed all stratification systems

Observational data: associations, not effects.

Further findings

Death because of DTC · median follow-up 9 years

Died because of DTC
67 (7.8%)

Original publication

Evaluating Disease-specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer. J Clin Endocrinol Metab. Published 12 December 2022. doi:10.1210/clinem/dgac721

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.